Cellceutix reports increased net loss for 2017 Q1

Biopharmaceutical company Cellceutix has reported an increased net loss for its first quarter of fiscal year 2017.

For the quarter (end-September 30), the company reported a net loss of $3.0 million, up from $2.6 million in the same quarter of 2015. The company attributed the net loss to an increase in expenses for operating and research and development.